LTBP-3 Antibodies

Santa Cruz Biotechnology delivers a wide array of LTBP-3 monoclonal antibodies for research focused on latent transforming growth factor-beta binding protein 3. LTBP-3 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). LTBP-3 plays a critical role in the regulation of TGF-beta, a key cytokine involved in numerous cellular processes such as cell growth, differentiation, and immune response. By binding to TGF-beta, LTBP-3 helps to maintain the latent form of this growth factor, influencing its availability and activity in the extracellular matrix. Understanding LTBP-3 function is essential for elucidating its contributions to various pathological conditions, including fibrosis and cancer. Research has shown that LTBP-3 expression patterns vary across different tissue types, suggesting distinct regulatory mechanisms in various biological systems. The interaction between LTBP-3 and TGF-beta signaling pathways continues to reveal new insights into developmental processes and disease progression. Investigating LTBP-3 has led to significant discoveries in understanding tissue repair and regeneration mechanisms. Santa Cruz Biotechnology monoclonal antibodies for LTBP-3 enable researchers worldwide to advance scientific understanding of TGF-beta signaling pathways and their impact on human health.